PLoS ONEplosplosonePLoS ONE1932-6203 Public Library of Science San Francisco, USA PONE-D-10-0218310.1371/journal.pone.0015801 Research Article Biology Biochemistry Enzymes Microbiology Industrial microbiology Model organisms Prokaryotic models Escherichia coli Molecular cell biology Synthetic biology Microbiology Molecular Biology Biochemistry Targeted Amino-Terminal Acetylation of Recombinant Proteins in E. coliAmino-Terminal Acetylation in E. coli Johnson Matthew Coulton Arthur T. Geeves Michael A. Mulvihill Daniel P. * School of Biosciences, University of Kent, Canterbury, United Kingdom Herman Christophe Editor Baylor College of Medicine, United States of America * E-mail: d.p.mulvihill@kent.ac.uk

Conceived and designed the experiments: MAG DPM. Performed the experiments: MJ ATC DPM. Analyzed the data: MJ ATC DPM MAG. Contributed reagents/materials/analysis tools: MJ ATC DPM MAG. Wrote the paper: DPM MAG.

The authors have declared that no competing interests exist.

 2010 23 12 2010 512e15801 21 9 2010 23 11 2010 2010Johnson et alThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

One major limitation in the expression of eukaryotic proteins in bacteria is an inability to post-translationally modify the expressed protein. Amino-terminal acetylation is one such modification that can be essential for protein function. By co-expressing the fission yeast NatB complex with the target protein in E.coli, we report a simple and widely applicable method for the expression and purification of functional N-terminally acetylated eukaryotic proteins.

This work was funded by grants from the Wellcome Trust (085309), BBSRC (BB/F011784/1) and a University of Kent Innovation bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Introduction

In eukaryotic cells up to 98% proteins are N-terminally acetylated [1]. In many of these cases the acetylation is required for normal function e.g. α-crystallin, S-adenosylmethionine decarboxylase, thymosin and components of the 26S proteasome regulatory particle [2], [3], [4], [5]. In others N-terminal acetylation is a regulatory event e.g. fission yeast tropomyosin (Tm), Cdc8 [6]. In all cases the acetylation stabilises the protein by protecting it from degradation via N-terminal proteases.

How acetylation is brought about and how it changes protein function is poorly understood. Amino terminal acetylation within eukaryotes is carried out by N-α-acetyltransferase (Nat) complexes and is thought to take place co-translationally at the ribosome [7]. Currently 3 distinct classes of Nat complexes have been identified (NatA, B & C) [8], each composed of distinct catalytic and regulatory subunits. These complexes associate with specific and distinct target sequences at the amino terminus of elongating polypeptides.

The lack of Nat complexes or their equivalents within prokaryotes has prevented the use of E. coli expression systems for producing N-terminally acetylated proteins. Although gram-negative bacteria, such as E. coli, are capable of acetylating components of their own proteome, it occurs infrequently and is undertaken by a discrete molecular pathway. The inability to produce N-terminally acetylated eukaryotic proteins in E. coli limits the ability to generate low cost proteins & peptides. Researchers are currently dependent upon the use of comparatively expensive and time-consuming chemical acetylation or eukaryotic expression systems to complete functional studies on these proteins.

Here we describe a novel system in which it is possible to produce N-terminally acetylated recombinant proteins from bacteria. By co-expressing the fission yeast NatB acetylation complex together with the target NatB substrate protein we have been able to acetylate and purify proteins from within E. coli. We went on to show that the same expression system works for each of the three N-terminal recognition sequences and successfully expressed acetylated human (Tropomyosin and Spartin) and yeast proteins (S. pombe Cdc8 and S. cerevisiae Tfs1). This simple and reliable methodology has the potential to allow significant savings in time and money over current techniques for generating amino-terminally acetylated recombinant polypeptides for both research and industrial applications.

 Results

Using a system based on the fission yeast NatB acetylation complex (Figure 1A), we have developed a method in which these are co-expressed together with target substrates in E. coli (Figure 1B). NatB conjugates an acetyl group on the amino terminal methionine of peptides with Met.Asp, Met.Glu or Met.Asn as N-terminal sequences and therefore acetylate a significant proportion of eukaryotic proteins [8].

10.1371/journal.pone.0015801.g001 Generation of an <italic>E.coli</italic> NatB complex co-expression strain.

(A) Introns (black regions) were removed from genes encoding the NatB subunits Naa20 (white) and Naa25 (grey), and the subsequent cDNAs were each cloned into the same bacterial expression vector (pNatB). (B) Whole cell lysates from BL21-DE3 cells containing either pNatB alone (left), pTarget (encoding the target protein alone - middle), or both pNatB & pTarget (right) were separated by SDS-PAGE following IPTG induction and visualised using coomassie stain. These data confirmed the successful co-expression of the NatB complex and target proteins in E. coli.

Mammalian striated muscle α-Tropomyosin (Tm) is an evolutionarily conserved actin binding protein that is a substrate for the NatB complex [9], [10]. This protein is readily expressed and purified from E. coli [11], and since the amino-terminal acetylation is essential for actin binding [11] it provides a simple test system for successful acetylation.

We co-transformed E.coli cells with the plasmid containing cDNA encoding for both catalytic (Naa20) and regulatory (Naa25) subunits of the fission yeast NatB complex, together with a plasmid encoding the murine α-skeletal Tm gene. These genes were co-induced (Figure 1B) and the Tm was isolated. Tm was purified and mass spectroscopy analysis shown that >60% of the Tm had been successfully acetylated (Figure 2A). This is in contrast to Skeletal Tm purified from standard BL21 cells which remained unacetylated (Figure 2B). The acetylated protein was shown, using an actin sedimentation assay, to bind actin with an affinity equivalent to the native protein [12], whereas the non acetylated protein failed to bind at Tm concentrations of up to 20 µM (Table 1). The muscle Tm has the N-terminal sequence Met-Glu. We went on to acetylate further proteins to confirm this prokaryote acetylation system worked for proteins with each of the NatB recognition sequences. Functional fission yeast Tm (Cdc8, N-terminal: Met.Asp) [6] was successfully produced (Figure 3) and bound to actin filament six times tighter than unacetylated yeast Tm [6]. Both human Spartin [6] (N-terminal: Met.Glu) and the budding yeast Tfs1 [13] (N-terminal: Met.Asn) proteins were also successfully acetylated and purified using affinity chromatography (data not shown) from E. coli (Table 1).

10.1371/journal.pone.0015801.g002 Electron-spray mass-spectroscopy spectra for α-SkTm.

α-SkTm tropomyosin was purified from either E. coli BL21-pNatB cells (A) or E. coli BL21 cells (B). The undeconvolved mass charge envelope spectra show the purity of the proteins. Deconvolution of these data indicates that while ∼60% of the α-SkTm purified from BL21-pNatB cells is acetylated (additional 42 daltons mass), all of the Tm purified from standard BL21 cells remains unacetylated.

 10.1371/journal.pone.0015801.g003 Electron-spray mass-spectroscopy spectra for <italic>S. pombe</italic> Cdc8.

Cdc8 was purified from E. coli BL21-pNatB cells. The un-deconvolved mass charge envelope spectra show the purity of the protein. Deconvolution of this data indicates that all of the Cdc8 purified from BL21-pNatB cells is acetylated.

 10.1371/journal.pone.0015801.t001 Yield, acetylation efficiency and actin affinity of target proteins heterologously expressed in <italic>E. coli</italic>.
Protein Host N-term % Acetylated in BL21 pNatB* Protein Yield3 KD for actin
- NatB + NatB - NatB + NatB
Cdc8 Tm S. pombe M-D- 100%1,2 8.8 19.2 2.76 µM 0.45 µM
Skeletal Tm M. musculus M-E- 60%1,2 9.36 20.22 >20 µM 0.6 µM
Tfs1 S. cerevisiae M-N- 30%1,2 1.6 5.4 - -
Spartin H. sapiens M-E- 25%2 0.315 0.332 - -

1 or 2-dimensional gel electrophoresis2

;

mg purified protein/litre of culture.

Three of the four target proteins expressed (SkTm, Cdc8, Tfs1) showed a 2–3 fold increase in yield when co-expressed with the NatB complex compared to standard expression systems. Whether this reflects an increase in the stability of the acetylated protein is unclear, and is currently under investigation. However the level of acetylation was variable from 25–100% for the four proteins. This may be improved by temporal control of expression to ensure NatB is both expressed and functional before the target protein is expressed. We have not yet examined whether the endogenous E. coli proteins were acetylated in the BL21-NatB cells, but if this was the case there was no associated detrimental effect upon cell morphology or growth.

 Discussion

Nat complex dependent amino-terminal acetylation has been assumed to occur on the eukaryote ribosome. If this were to be the case then our result would demonstrate that NatB is able to function at either the pro- or eukaryotic ribosome. However, as the composition of the bacterial and eukaryote ribosomes differ significantly it is uncertain how and where NatB functions within the bacterial cell, and is under further investigation.

The efficient and simple method we described in this paper has the potential to allow significant savings in time and money over current methods for chemically acetylating amino termini of many proteins and peptides, and also in improving yield during recombinant protein production. The ability to produce acetylated protein will now allow more detailed studies of the role of protein acetylation in protein stability, regulation of structure and function, as well as allowing the generate low cost proteins and peptides for the biotechnology & pharmaceutical industries.

 Materials and Methods Molecular Biology

naa20+ (SPCC16C4.12) and naa25+ (SPBC1215.02c) genes were amplified from genomic S. pombe DNA as Nde1-BamH1 and Sal1 fragments respectively and cloned into pGEM-T-Easy (Promega). Introns were removed sequentially by ligating blunt ended products of PCR reactions where appropriate primers had been used to amplify the entire plasmid lacking individual introns. Subsequent cDNAs were sequenced and cloned into pACYCduet (Novagen), each under the control of separate T7 promotors, to generate pACYCduet-naa20+-naa25+ (pNatB). BL21 DE3 cells were co-transformed with pACYCduet-naa20+-naa25+ and a pJC20 plasmid containing the cDNA encoding for the appropriate target protein also under the control of the T7 promoter (pTarget).

 Cell Culture

E. coli cells were cultured in NZY medium (1.0% Casein hydolysate (NZ amine), 0.5% NaCl, 0.5% yeast extract, 20 mM D-Glucose, 12.5 mM MgCl2 and 12.5 mM MgSO4) supplemented with appropriate antibiotics, and were grown in baffled Erlenmeyer flasks at 37°C with vigorous shaking. T7 dependent expression was induced by addition of IPTG (100 µg/ml final concentration) once cell cultures had reached an OD600 of 0.4–0.5. Cells were harvested 4 hr after induction with IPTG. Protein expression was assessed by separating whole cell lysates using SDS-PAGE and visualizing proteins with Coomassie blue stain.

 Biochemical techniques

Tropomyosin proteins were expressed and purified as described previously [6], while poly-histidine tagged proteins were purified on nickel columns (Qiagen) in denaturing conditions (8 M urea, 0.1 M NaH2PO4 0.01 M Tris-Cl). Protein concentrations were determined using 280 nm extinction coefficients of 2,980 cm−1, 27,600 cm−1, 27,550 cm−1 and 64,070 cm−1 for Cdc8, α-SkTm, Tfs1 and Spartin respectively. Protein mass was determined using a Finnegan Mat LCQ ion-trap mass spectroscope. Cosedimentation assays were performed at 25°C as described previously [14]. We made use of the fact that acetylated SkTm migrates separately to the unacetylated form on SDS-PAGE to determine the KD for of the acetylated population of Tm.

We thank both S. Lynn and N. Adamek for technical assistance and Kay Barr for comments on the manuscript.

 References ArnesenTVan DammePPolevodaBHelsensKEvjenthR 2009 Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proc Natl Acad Sci U S A 106 8157 8162 GroenenPJMerckKBde JongWWBloemendalH 1994 Structure and modifications of the junior chaperone alpha-crystallin. From lens transparency to molecular pathology. Eur J Biochem 225 1 19 WadaMShirahataA 2010 Identification of the primary structure and post-translational modification of rat S-adenosylmethionine decarboxylase. Biol Pharm Bull 33 891 894 KikuchiJIwafuneYAkiyamaTOkayamaANakamuraH 2010 Co- and post-translational modifications of the 26S proteasome in yeast. Proteomics 10 2769 2779 MannherzHGMazurAJJockuschB 2010 Repolymerization of actin from actin:thymosin beta4 complex induced by diaphanous related formins and gelsolin. Ann N Y Acad Sci 1194 36 43 SkoumplaKCoultonATLehmanWGeevesMAMulvihillDP 2007 Acetylation regulates tropomyosin function in the fission yeast Schizosaccharomyces pombe. J Cell Sci 120 1635 1645 GautschiMJustSMunARossSRucknagelP 2003 The yeast N(alpha)-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides. Mol Cell Biol 23 7403 7414 PolevodaBArnesenTShermanF 2009 A synopsis of eukaryotic Nalpha-terminal acetyltransferases: nomenclature, subunits and substrates. BMC Proc 3 Suppl 6 S2 PolevodaBCardilloTSDoyleTCBediGSShermanF 2003 Nat3p and Mdm20p are required for function of yeast NatB Nalpha-terminal acetyltransferase and of actin and tropomyosin. J Biol Chem 278 30686 30697 SingerJMShawJM 2003 Mdm20 protein functions with Nat3 protein to acetylate Tpm1 protein and regulate tropomyosin-actin interactions in budding yeast. Proc Natl Acad Sci U S A 100 7644 7649 UrbancikovaMHitchcock-DeGregoriSE 1994 Requirement of amino-terminal modification for striated muscle alpha-tropomyosin function. J Biol Chem 269 24310 24315 BoussoufSEMaytumRJaquetKGeevesMA 2007 Role of tropomyosin isoforms in the calcium sensitivity of striated muscle thin filaments. J Muscle Res Cell Motil 28 49 58 CaesarRBlombergA 2004 The stress-induced Tfs1p requires NatB-mediated acetylation to inhibit carboxypeptidase Y and to regulate the protein kinase A pathway. J Biol Chem 279 38532 38543 MaytumRGeevesMAKonradM 2000 Actomyosin regulatory properties of yeast tropomyosin are dependent upon N-terminal modification. Biochemistry 39 11913 11920